Consolidated Cash Flow Statement - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Operating Activities
Net income	$ 1,066	$ 1,595	$ 2,221
Depreciation and amortization	746	862	863
Asset impairments	22	42	45
Stock-based compensation	75	52	92
Deferred income taxes	(255)	63	151
Net (gains) losses on asset dispositions	17	21	11
Equity companies' earnings (in excess of) less than dividends paid	(10)	28	(36)
(Increase) decrease in operating working capital	(445)	(176)	(158)
Postretirement benefits	930	(102)	(158)
Charge for Venezuelan Balance Sheet Remeasurement and Deconsolidation	153
Charges related to Venezuelan Operations		462	36
Other	7	(2)	(27)
Cash Provided by Operations	2,306	2,845	3,040
Investing Activities
Capital spending	(1,056)	(1,039)	(953)
Acquisitions of businesses	0	0	(32)
Proceeds from dispositions of property	27	38	129
Proceeds from sales of investments	0	127	26
Investments in time deposits	(146)	(151)	(93)
Maturities of time deposits	164	239	94
Other	(39)	16	(15)
Cash Used for Investing	(1,050)	(770)	(844)
Financing Activities
Cash dividends paid	(1,272)	(1,256)	(1,223)
Change in short-term debt	303	721	(287)
Debt proceeds	1,100	1,257	890
Debt repayments	(553)	(123)	(544)
Redemption of redeemable preferred securities of subsidiary	0	(500)	0
Cash paid on redeemable preferred securities of subsidiaries	(3)	(34)	(27)
Proceeds from exercise of stock options	140	127	232
Acquisitions of common stock for the treasury	(861)	(1,939)	(1,216)
Cash transferred to Halyard Health, Inc. related to spin-off	0	(120)	0
Proceeds from (Payments to) Noncontrolling Interests	(151)	0	0
Other	(1)	(26)	(10)
Cash Used for Financing	(1,298)	(1,893)	(2,185)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(128)	(447)	(63)
Increase (Decrease) in Cash and Cash Equivalents	(170)	(265)	(52)
Cash and Cash Equivalents - Beginning of Year	789	1,054	1,106
Cash and Cash Equivalents - End of Year	$ 619	$ 789	$ 1,054